APO Research
Talk to an analyst

APO RESEARCH · REPORT

Albendazole

Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.

Selected research

Industry Growth & Trends

Global Albendazole Industry Growth and Trends Forecast to 2032

27 December 2025101 pages

Choose your research edition.

Industry ResearchAlbendazole Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Albendazole Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Albendazole Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Albendazole Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Albendazole Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

Albendazole is a high-efficiency and low-toxic broad-spectrum anthelmintic drug. It was successfully developed and marketed by Skipper in the 1980s. It can be used clinically to ward off roundworms, pinworms, tapeworms, whipworms, hookworms, and anastomosis. After being metabolized to sulfoxides or sulfones in the body, it inhibits the parasite's absorption of glucose, leading to depletion of the body's glycogen, or inhibits the fumarate reductase system, hinders the production of ATP, and makes the parasite unable to survive and reproduce. Albendazole is a benzimidazole derivative, which is rapidly metabolized into sulfoxide, sulfone alcohol and 2-aminosulfone alcohol in the body, selectively and irreversibly inhibits the cytoplasmic microtubule system of intestinal wall cells of parasites Polymerization, blocking its uptake of various nutrients and glucose, leading to depletion of endogenous glycogen, and inhibiting the fumarate reductase system, preventing the production of adenosine triphosphate, making the worm unable to survive and reproduce. Similar to mebendazole, albendazole can also cause the degeneration of cytoplasmic microtubules in the intestinal cells of worms and bind to its tubulin, causing intracellular transport blockage, resulting in the accumulation of secretory particles in the Golgi body, the cytoplasm is gradually dissolved, and the cells are completely absorbed Denaturation causes death of the worm. Albendazole completely kills hookworm eggs and whipworm eggs and partially kills roundworm eggs. In addition to killing and repelling various nematodes parasitic in animals, it also has obvious killing and repelling effects on tapeworms and cysticercosis.

This is a relatively concentrated market, mainly due to the particularity of the pharmaceutical industry, where there are higher operating licenses and barriers, technical barriers, capital barriers and environmental barriers, so the concentration is higher. From the perspective of the global market, the original research firm GSK's albendazole accounts for more than 40% of the entire industry and is the leading enterprise in the albendazole industry. From the perspective of the Chinese market, the market concentration is also relatively high. The main companies are Huazhong Pharmaceutical and Jiangsu Qihui, which together account for 70% of the domestic market.

Report Scope

Read the full market overview

This report provides a structured, data-driven view of the global Albendazole market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Albendazole market size, estimates, and forecasts are presented in terms of sales volume (K MT) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Albendazole market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Albendazole.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Albendazole market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Albendazole Market by Company

GlaxoSmithKline

Huazhong Pharmaceutical

Jiangsu Qihui

Sequent Scientific

K.A. Malle Pharmaceuticals

Lasa Supergenerics Limited

Zhongjia Pharmaceutical

Fredun Pharmaceuticals Ltd

Supharma Chem

Salius Pharma

Albendazole Segment by Type

Tablet

Capsule

Other

Albendazole Segment by Application

Human

Veterinary

Albendazole Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Albendazole market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Albendazole and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Albendazole.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Albendazole manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Albendazole in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Tablet Table 2. Major Company of Capsule Table 3. Major Company of Other Table 4. Global Albendazole Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Albendazole Sales by Type (2021-2026) & (K MT) Table 6. Global Albendazole Sales Market Share in Volume by Type (2021-2026) Table 7. Global Albendazole Sales by Type (2021-2026) & (US$ Million) Table 8. Global Albendazole Sales Market Share in Value by Type (2021-2026) Table 9. Global Albendazole Price by Type (2021-2026) & (USD/MT) Table 10. Global Albendazole Sales by Type (2027-2032) & (K MT) Table 11. Global Albendazole Sales Market Share in Volume by Type (2027-2032) Table 12. Global Albendazole Sales by Type (2027-2032) & (US$ Million) Table 13. Global Albendazole Sales Market Share in Value by Type (2027-2032) Table 14. Global Albendazole Price by Type (2027-2032) & (USD/MT) Table 15. North America Albendazole Sales by Type (2021-2026) & (K MT) Table 16. North America Albendazole Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Albendazole Sales by Type (2021-2026) & (K MT) Table 18. Europe Albendazole Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Albendazole Sales by Type (2021-2026) & (K MT) Table 20. Asia-Pacific Albendazole Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Albendazole Sales by Type (2021-2026) & (K MT) Table 22. Latin America Albendazole Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Albendazole Sales by Type (2021-2026) & (K MT) Table 24. Middle East and Africa Albendazole Sales by Type (2021-2026) & (US$ Million) Table 25. Albendazole Industry Trends Table 26. Albendazole Industry Drivers Table 27. Albendazole Industry Opportunities and Challenges Table 28. Albendazole Industry Restraints Table 29. Global Albendazole Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Albendazole Revenue Market Share by Company (2021-2026) Table 31. Global Albendazole Sales by Company (2021-2026) & (K MT) Table 32. Global Albendazole Sales Share by Company (2021-2026) Table 33. Global Albendazole Market Price by Company (2021-2026) & (USD/MT) Table 34. Global Albendazole Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Albendazole Major Company Production Sites and Headquarters Table 36. Global Albendazole Company, Product Type & Application Table 37. Global Albendazole Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Albendazole by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Albendazole Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Albendazole Sales by Region (2021-2026) & (K MT) Table 42. Global Albendazole Sales Market Share in Volume by Region (2021-2026) Table 43. Global Albendazole Sales by Region (2021-2026) & (US$ Million) Table 44. Global Albendazole Sales Market Share in Value by Region (2021-2026) Table 45. Global Albendazole Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 46. Global Albendazole Sales by Region (2027-2032) & (K MT) Table 47. Global Albendazole Sales Market Share in Volume by Region (2027-2032) Table 48. Global Albendazole Sales by Region (2027-2032) & (US$ Million) Table 49. Global Albendazole Sales Market Share in Value by Region (2027-2032) Table 50. Global Albendazole Sales (K MT), Value (US$ Million), Price (USD/MT) and Gross Margin (2027-2032) Table 51. Global Albendazole Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Albendazole Sales by Application (2021-2026) & (K MT) Table 53. Global Albendazole Sales Market Share in Volume by Application (2021-2026) Table 54. Global Albendazole Sales by Application (2021-2026) & (US$ Million) Table 55. Global Albendazole Sales Market Share in Value by Application (2021-2026) Table 56. Global Albendazole Price by Application (2021-2026) & (USD/MT) Table 57. Global Albendazole Sales by Application (2027-2032) & (K MT) Table 58. Global Albendazole Sales Market Share in Volume by Application (2027-2032) Table 59. Global Albendazole Sales by Application (2027-2032) & (US$ Million) Table 60. Global Albendazole Sales Market Share in Value by Application (2027-2032) Table 61. Global Albendazole Price by Application (2027-2032) & (USD/MT) Table 62. North America Albendazole Sales by Application (2021-2026) & (K MT) Table 63. North America Albendazole Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Albendazole Sales by Application (2021-2026) & (K MT) Table 65. Europe Albendazole Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Albendazole Sales by Application (2021-2026) & (K MT) Table 67. Asia-Pacific Albendazole Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Albendazole Sales by Application (2021-2026) & (K MT) Table 69. Latin America Albendazole Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Albendazole Sales by Application (2021-2026) & (K MT) Table 71. Middle East and Africa Albendazole Sales by Application (2021-2026) & (US$ Million) Table 72. GlaxoSmithKline Company Information Table 73. GlaxoSmithKline Business Overview Table 74. GlaxoSmithKline Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 75. GlaxoSmithKline Albendazole Product Portfolio Table 76. GlaxoSmithKline Recent Development Table 77. Huazhong Pharmaceutical Company Information Table 78. Huazhong Pharmaceutical Business Overview Table 79. Huazhong Pharmaceutical Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 80. Huazhong Pharmaceutical Albendazole Product Portfolio Table 81. Huazhong Pharmaceutical Recent Development Table 82. Jiangsu Qihui Company Information Table 83. Jiangsu Qihui Business Overview Table 84. Jiangsu Qihui Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 85. Jiangsu Qihui Albendazole Product Portfolio Table 86. Jiangsu Qihui Recent Development Table 87. Sequent Scientific Company Information Table 88. Sequent Scientific Business Overview Table 89. Sequent Scientific Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 90. Sequent Scientific Albendazole Product Portfolio Table 91. Sequent Scientific Recent Development Table 92. K.A. Malle Pharmaceuticals Company Information Table 93. K.A. Malle Pharmaceuticals Business Overview Table 94. K.A. Malle Pharmaceuticals Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 95. K.A. Malle Pharmaceuticals Albendazole Product Portfolio Table 96. K.A. Malle Pharmaceuticals Recent Development Table 97. Lasa Supergenerics Limited Company Information Table 98. Lasa Supergenerics Limited Business Overview Table 99. Lasa Supergenerics Limited Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 100. Lasa Supergenerics Limited Albendazole Product Portfolio Table 101. Lasa Supergenerics Limited Recent Development Table 102. Zhongjia Pharmaceutical Company Information Table 103. Zhongjia Pharmaceutical Business Overview Table 104. Zhongjia Pharmaceutical Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 105. Zhongjia Pharmaceutical Albendazole Product Portfolio Table 106. Zhongjia Pharmaceutical Recent Development Table 107. Fredun Pharmaceuticals Ltd Company Information Table 108. Fredun Pharmaceuticals Ltd Business Overview Table 109. Fredun Pharmaceuticals Ltd Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 110. Fredun Pharmaceuticals Ltd Albendazole Product Portfolio Table 111. Fredun Pharmaceuticals Ltd Recent Development Table 112. Supharma Chem Company Information Table 113. Supharma Chem Business Overview Table 114. Supharma Chem Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 115. Supharma Chem Albendazole Product Portfolio Table 116. Supharma Chem Recent Development Table 117. Salius Pharma Company Information Table 118. Salius Pharma Business Overview Table 119. Salius Pharma Albendazole Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2021-2026) Table 120. Salius Pharma Albendazole Product Portfolio Table 121. Salius Pharma Recent Development Table 122. North America Albendazole Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 123. North America Albendazole Sales by Country (2021-2026) & (K MT) Table 124. North America Albendazole Sales Market Share by Country (2021-2026) Table 125. North America Albendazole Sales Forecast by Country (2027-2032) & (K MT) Table 126. North America Albendazole Sales Market Share Forecast by Country (2027-2032) Table 127. North America Albendazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Albendazole Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Albendazole Market Share by Country (2021-2026) Table 130. North America Albendazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Albendazole Market Share Forecast by Country (2027-2032) Table 132. Europe Albendazole Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 133. Europe Albendazole Sales by Country (2021-2026) & (K MT) Table 134. Europe Albendazole Sales Market Share by Country (2021-2026) Table 135. Europe Albendazole Sales Forecast by Country (2027-2032) & (K MT) Table 136. Europe Albendazole Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Albendazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Albendazole Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Albendazole Market Share by Country (2021-2026) Table 140. Europe Albendazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Albendazole Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Albendazole Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Albendazole Sales by Country (2021-2026) & (K MT) Table 144. Asia-Pacific Albendazole Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Albendazole Sales Forecast by Country (2027-2032) & (K MT) Table 146. Asia-Pacific Albendazole Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Albendazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Albendazole Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Albendazole Market Share by Country (2021-2026) Table 150. Asia-Pacific Albendazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Albendazole Market Share Forecast by Country (2027-2032) Table 152. Latin America Albendazole Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 153. Latin America Albendazole Sales by Country (2021-2026) & (K MT) Table 154. Latin America Albendazole Sales Market Share by Country (2021-2026) Table 155. Latin America Albendazole Sales Forecast by Country (2027-2032) & (K MT) Table 156. Latin America Albendazole Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Albendazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Albendazole Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Albendazole Market Share by Country (2021-2026) Table 160. Latin America Albendazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Albendazole Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Albendazole Market Size Growth Rate (CAGR) by Country (K MT): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Albendazole Sales by Country (2021-2026) & (K MT) Table 164. Middle East and Africa Albendazole Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Albendazole Sales Forecast by Country (2027-2032) & (K MT) Table 166. Middle East and Africa Albendazole Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Albendazole Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Albendazole Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Albendazole Market Share by Country (2021-2026) Table 170. Middle East and Africa Albendazole Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Albendazole Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Albendazole Distributors List Table 175. Albendazole Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Albendazole Image Figure 2. Global Albendazole Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Albendazole Market Size (2021-2032) & (US$ Million) Figure 4. Global Albendazole Sales (2021-2032) & (K MT) Figure 5. Tablet Image Figure 6. Global Tablet Sales YoY Growth (2021-2032) & (K MT) Figure 7. Capsule Image Figure 8. Global Capsule Sales YoY Growth (2021-2032) & (K MT) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K MT) Figure 11. Global Albendazole Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Albendazole Market Share by Type 2025 VS 2032 Figure 13. North America Albendazole Sales Market Share in Volume by Type in 2025 Figure 14. North America Albendazole Sales Market Share in Value by Type in 2025 Figure 15. Europe Albendazole Sales Market Share in Volume by Type in 2025 Figure 16. Europe Albendazole Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Albendazole Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Albendazole Sales Market Share in Value by Type in 2025 Figure 19. Latin America Albendazole Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Albendazole Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Albendazole Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Albendazole Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Albendazole Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Human Image Figure 26. Global Human Sales YoY Growth (2021-2032) & (K MT) Figure 27. Veterinary Image Figure 28. Global Veterinary Sales YoY Growth (2021-2032) & (K MT) Figure 29. Global Albendazole Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Albendazole Market Share by Application 2025 VS 2032 Figure 31. North America Albendazole Sales Market Share in Volume by Application in 2025 Figure 32. North America Albendazole Sales Market Share in Value by Application in 2025 Figure 33. Europe Albendazole Sales Market Share in Volume by Application in 2025 Figure 34. Europe Albendazole Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Albendazole Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Albendazole Sales Market Share in Value by Application in 2025 Figure 37. Latin America Albendazole Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Albendazole Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Albendazole Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Albendazole Sales Market Share in Value by Application in 2025 Figure 41. North America Albendazole Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 42. North America Albendazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Albendazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Albendazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Albendazole Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 46. Europe Albendazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Albendazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Albendazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Albendazole Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 50. Asia-Pacific Albendazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Albendazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Albendazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Albendazole Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 54. Latin America Albendazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Albendazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Albendazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Albendazole Sales by Country: 2021 VS 2025 VS 2032 (K MT) Figure 58. Middle East and Africa Albendazole Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Albendazole Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Albendazole Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Albendazole Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Albendazole Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Capsule
  • Other
Applications
  • Human
  • Veterinary
Companies covered
  • GlaxoSmithKline
  • Huazhong Pharmaceutical
  • Jiangsu Qihui
  • Sequent Scientific
  • K.A. Malle Pharmaceuticals
  • Lasa Supergenerics Limited
  • Zhongjia Pharmaceutical
  • Fredun Pharmaceuticals Ltd
  • Supharma Chem
  • Salius Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Albendazole Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Albendazole Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Albendazole Market by Type
  6. 1.3.1 Tablet
  7. 1.3.2 Capsule
  8. 1.3.3 Other
  9. 1.4 Global Albendazole Market Size by Type
  10. 1.4.1 Global Albendazole Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Albendazole Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Albendazole Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Albendazole Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Albendazole Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Albendazole Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Albendazole Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Albendazole Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Albendazole Industry Trends
  2. 2.2 Albendazole Industry Drivers
  3. 2.3 Albendazole Industry Opportunities and Challenges
  4. 2.4 Albendazole Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Albendazole Revenue (2021-2026)
  2. 3.2 Global Top Players by Albendazole Sales (2021-2026)
  3. 3.3 Global Top Players by Albendazole Price (2021-2026)
  4. 3.4 Global Albendazole Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Albendazole Major Company Production Sites & Headquarters
  6. 3.6 Global Albendazole Company, Product Type & Application
  7. 3.7 Global Albendazole Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Albendazole Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Albendazole Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Albendazole Tier 1, Tier 2, and Tier 3
4 Albendazole Regional Status and Outlook
  1. 4.1 Global Albendazole Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Albendazole Historic Market Size by Region
  3. 4.2.1 Global Albendazole Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Albendazole Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Albendazole Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Albendazole Forecasted Market Size by Region
  7. 4.3.1 Global Albendazole Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Albendazole Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Albendazole Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Albendazole by Application
  1. 5.1 Albendazole Market by Application
  2. 5.1.1 Human
  3. 5.1.2 Veterinary
  4. 5.2 Global Albendazole Market Size by Application
  5. 5.2.1 Global Albendazole Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Albendazole Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Albendazole Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Albendazole Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Albendazole Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Albendazole Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Albendazole Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Albendazole Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GlaxoSmithKline
  2. 6.1.1 GlaxoSmithKline Company Information
  3. 6.1.2 GlaxoSmithKline Business Overview
  4. 6.1.3 GlaxoSmithKline Albendazole Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GlaxoSmithKline Albendazole Product Portfolio
  6. 6.1.5 GlaxoSmithKline Recent Developments
  7. 6.2 Huazhong Pharmaceutical
  8. 6.2.1 Huazhong Pharmaceutical Company Information
  9. 6.2.2 Huazhong Pharmaceutical Business Overview
  10. 6.2.3 Huazhong Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Huazhong Pharmaceutical Albendazole Product Portfolio
  12. 6.2.5 Huazhong Pharmaceutical Recent Developments
  13. 6.3 Jiangsu Qihui
  14. 6.3.1 Jiangsu Qihui Company Information
  15. 6.3.2 Jiangsu Qihui Business Overview
  16. 6.3.3 Jiangsu Qihui Albendazole Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Qihui Albendazole Product Portfolio
  18. 6.3.5 Jiangsu Qihui Recent Developments
  19. 6.4 Sequent Scientific
  20. 6.4.1 Sequent Scientific Company Information
  21. 6.4.2 Sequent Scientific Business Overview
  22. 6.4.3 Sequent Scientific Albendazole Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sequent Scientific Albendazole Product Portfolio
  24. 6.4.5 Sequent Scientific Recent Developments
  25. 6.5 K.A. Malle Pharmaceuticals
  26. 6.5.1 K.A. Malle Pharmaceuticals Company Information
  27. 6.5.2 K.A. Malle Pharmaceuticals Business Overview
  28. 6.5.3 K.A. Malle Pharmaceuticals Albendazole Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 K.A. Malle Pharmaceuticals Albendazole Product Portfolio
  30. 6.5.5 K.A. Malle Pharmaceuticals Recent Developments
  31. 6.6 Lasa Supergenerics Limited
  32. 6.6.1 Lasa Supergenerics Limited Company Information
  33. 6.6.2 Lasa Supergenerics Limited Business Overview
  34. 6.6.3 Lasa Supergenerics Limited Albendazole Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Lasa Supergenerics Limited Albendazole Product Portfolio
  36. 6.6.5 Lasa Supergenerics Limited Recent Developments
  37. 6.7 Zhongjia Pharmaceutical
  38. 6.7.1 Zhongjia Pharmaceutical Company Information
  39. 6.7.2 Zhongjia Pharmaceutical Business Overview
  40. 6.7.3 Zhongjia Pharmaceutical Albendazole Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Zhongjia Pharmaceutical Albendazole Product Portfolio
  42. 6.7.5 Zhongjia Pharmaceutical Recent Developments
  43. 6.8 Fredun Pharmaceuticals Ltd
  44. 6.8.1 Fredun Pharmaceuticals Ltd Company Information
  45. 6.8.2 Fredun Pharmaceuticals Ltd Business Overview
  46. 6.8.3 Fredun Pharmaceuticals Ltd Albendazole Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Fredun Pharmaceuticals Ltd Albendazole Product Portfolio
  48. 6.8.5 Fredun Pharmaceuticals Ltd Recent Developments
  49. 6.9 Supharma Chem
  50. 6.9.1 Supharma Chem Company Information
  51. 6.9.2 Supharma Chem Business Overview
  52. 6.9.3 Supharma Chem Albendazole Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Supharma Chem Albendazole Product Portfolio
  54. 6.9.5 Supharma Chem Recent Developments
  55. 6.10 Salius Pharma
  56. 6.10.1 Salius Pharma Company Information
  57. 6.10.2 Salius Pharma Business Overview
  58. 6.10.3 Salius Pharma Albendazole Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Salius Pharma Albendazole Product Portfolio
  60. 6.10.5 Salius Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Albendazole Sales by Country
  2. 7.1.1 North America Albendazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Albendazole Sales by Country (2021-2026)
  4. 7.1.3 North America Albendazole Sales Forecast by Country (2027-2032)
  5. 7.2 North America Albendazole Market Size by Country
  6. 7.2.1 North America Albendazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Albendazole Market Size by Country (2021-2026)
  8. 7.2.3 North America Albendazole Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Albendazole Sales by Country
  2. 8.1.1 Europe Albendazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Albendazole Sales by Country (2021-2026)
  4. 8.1.3 Europe Albendazole Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Albendazole Market Size by Country
  6. 8.2.1 Europe Albendazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Albendazole Market Size by Country (2021-2026)
  8. 8.2.3 Europe Albendazole Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Albendazole Sales by Country
  2. 9.1.1 Asia-Pacific Albendazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Albendazole Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Albendazole Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Albendazole Market Size by Country
  6. 9.2.1 Asia-Pacific Albendazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Albendazole Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Albendazole Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Albendazole Sales by Country
  2. 10.1.1 South America Albendazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Albendazole Sales by Country (2021-2026)
  4. 10.1.3 South America Albendazole Sales Forecast by Country (2027-2032)
  5. 10.2 South America Albendazole Market Size by Country
  6. 10.2.1 South America Albendazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Albendazole Market Size by Country (2021-2026)
  8. 10.2.3 South America Albendazole Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Albendazole Sales by Country
  2. 11.1.1 Middle East and Africa Albendazole Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Albendazole Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Albendazole Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Albendazole Market Size by Country
  6. 11.2.1 Middle East and Africa Albendazole Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Albendazole Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Albendazole Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Albendazole Value Chain Analysis
  2. 12.1.1 Albendazole Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Albendazole Production Mode & Process
  7. 12.2 Albendazole Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Albendazole Distributors
  10. 12.2.3 Albendazole Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst